Status:
RECRUITING
Assessing the Role of Mitochondrial Dysfunction in Primary Progressive Multiple Sclerosis
Lead Sponsor:
IRCCS San Raffaele
Collaborating Sponsors:
Azienda Socio Sanitaria Territoriale della Valle Olona
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this project is to study genetic determinants of mitochondrial impairment in primary progressive multiple sclerosis. Specific aims are: 1) identify mitochondrial-related pathways, inher...
Detailed Description
Multiple Sclerosis is a major cause of neurological disability, with a high socio-economic impact that increases as disability progresses. Effective treatment of primary progressive multiple sclerosis...
Eligibility Criteria
Inclusion
- Patients affected by primary progressive or relapsing remitting multiple sclerosis
- Patient able to provide informed consent
Exclusion
- Individuals with \< 18 years
- Patients not affected by primary progressive or relapsing remitting multiple sclerosis
Key Trial Info
Start Date :
September 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2025
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT06025903
Start Date
September 20 2021
End Date
May 30 2025
Last Update
March 22 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele
Milan, MI, Italy, 20132
2
ASST della Valle Olona - Ospedale di Gallarate
Gallarate, VA, Italy, 21013